Red Nucleus Acquires PPM Advisory Group and OrtleyBio

Red Nucleus announced that it has acquired PPM Advisory Group and OrtleyBio. It is a leading provider of scientific operations and communications services to biopharmaceutical companies and brands. The company has a primary focus on oncology and haematology therapeutic areas.

The companies offer commercial, medical affairs, and MSL content development; planning and training support, advisory boards, competitive landscape analysis, sales representative training support, and conferences/congress coverage. It also brings new client relationships and touches points for the combined business. PPM’s solutions align closely with RN’s existing Commercial and Medical Communications businesses.

Rhino Mariconda, PPM Founder shared the excitement to join the Red Nucleus family. They also added that they can provide expanded services to our current clients while helping them develop and commercialize treatments for patients. Red Nucleus is known to deliver best-in-class services and has an employee and client-service focused culture, which melds well with the PPM culture.

Ian Kelly, chief executive officer of Red nucleus said that they are thrilled for Rino and the PPM team to join the family. The combination of PPM and RN will collectively help us expand both within current therapeutic areas and services, as well as grow into new areas and offerings. PPM has a deep bench of advanced-degreed and seasoned medical writers and staff who produce high-quality content. They are the talented team members to build upon the strong historical reputation of both RN and PPM while delivering leading science-first services that our clients expect and deserve. Red Nucleus is headquartered in Yardley, PA. The company also has offices in Malvern, Boston, Toronto, Canada; London, UK; Stockholm, Sweden; Pune, India; and Tokyo, Japan.